JP2005536494A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005536494A5 JP2005536494A5 JP2004520148A JP2004520148A JP2005536494A5 JP 2005536494 A5 JP2005536494 A5 JP 2005536494A5 JP 2004520148 A JP2004520148 A JP 2004520148A JP 2004520148 A JP2004520148 A JP 2004520148A JP 2005536494 A5 JP2005536494 A5 JP 2005536494A5
- Authority
- JP
- Japan
- Prior art keywords
- syndrome
- diabetes
- pharmaceutical composition
- prostate
- lesions including
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 3
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 210000002307 Prostate Anatomy 0.000 claims 2
- 230000003902 lesions Effects 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 201000010874 syndrome Diseases 0.000 claims 2
- 206010003210 Arteriosclerosis Diseases 0.000 claims 1
- 210000004369 Blood Anatomy 0.000 claims 1
- 210000001072 Colon Anatomy 0.000 claims 1
- 206010011401 Crohn's disease Diseases 0.000 claims 1
- 208000002249 Diabetes Complications Diseases 0.000 claims 1
- 206010012601 Diabetes mellitus Diseases 0.000 claims 1
- 206010012655 Diabetic complications Diseases 0.000 claims 1
- 210000004392 Genitalia Anatomy 0.000 claims 1
- 206010062060 Hyperlipidaemia Diseases 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 208000006575 Hypertriglyceridemia Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 206010022489 Insulin resistance Diseases 0.000 claims 1
- 206010073094 Intraductal proliferative breast lesion Diseases 0.000 claims 1
- 210000004072 Lung Anatomy 0.000 claims 1
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 208000001132 Osteoporosis Diseases 0.000 claims 1
- 210000002784 Stomach Anatomy 0.000 claims 1
- 208000001072 Type 2 Diabetes Mellitus Diseases 0.000 claims 1
- 230000002159 abnormal effect Effects 0.000 claims 1
- 201000005794 allergic hypersensitivity disease Diseases 0.000 claims 1
- 201000001320 atherosclerosis Diseases 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 201000003149 breast fibroadenoma Diseases 0.000 claims 1
- 235000014113 dietary fatty acids Nutrition 0.000 claims 1
- 239000000194 fatty acid Substances 0.000 claims 1
- 150000004665 fatty acids Chemical class 0.000 claims 1
- 230000002496 gastric Effects 0.000 claims 1
- 201000001421 hyperglycemia Diseases 0.000 claims 1
- 230000009610 hypersensitivity Effects 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 201000008255 invasive lobular carcinoma Diseases 0.000 claims 1
- 230000003211 malignant Effects 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 230000002611 ovarian Effects 0.000 claims 1
- 201000004681 psoriasis Diseases 0.000 claims 1
Claims (2)
- 糖尿病、２型糖尿病、インスリン抵抗、高血糖症、抗インスリン血症、血中脂肪酸値若しくはグリセロール値の上昇、高脂血症、肥満、高トリグリセリド血症、炎症、Ｘ症候群、糖尿病合併症、異常代謝症候群、またはアテローム性動脈硬化を治療するための、請求項１４の薬学的組成物。
- 非浸潤性乳管癌および非浸潤性小葉癌を含む初期の悪性病変；胸の線維腺腫および前立腺上皮内腫瘍（ＰＩＮ）を含む前悪性病変；前立腺、大腸、卵巣、胃および肺の腫瘍；過敏性腸症候群；クローン病；胃潰瘍炎；および骨粗鬆症および乾癬を治療するための、請求項１４の薬学的組成物。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39450802P | 2002-07-09 | 2002-07-09 | |
| PCT/US2003/022149 WO2004004665A2 (en) | 2002-07-09 | 2003-07-02 | Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005536494A JP2005536494A (ja) | 2005-12-02 |
| JP2005536494A5 true JP2005536494A5 (ja) | 2006-06-08 |
| JP4579681B2 JP4579681B2 (ja) | 2010-11-10 |
Family
ID=30115727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004520148A Expired - Fee Related JP4579681B2 (ja) | 2002-07-09 | 2003-07-02 | 抗糖尿病薬および抗肥満薬として有用な置換ヘテロシクロ誘導体および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US7279485B2 (ja) |
| EP (1) | EP1656368A4 (ja) |
| JP (1) | JP4579681B2 (ja) |
| AU (1) | AU2003259131A1 (ja) |
| IS (1) | IS7630A (ja) |
| NO (1) | NO329938B1 (ja) |
| PL (1) | PL374860A1 (ja) |
| TW (1) | TW200422298A (ja) |
| WO (1) | WO2004004665A2 (ja) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7084156B2 (en) * | 2001-11-27 | 2006-08-01 | Merck & Co., Inc. | 2-Aminoquinoline compounds |
| CA2468159A1 (en) * | 2001-11-27 | 2003-06-05 | Merck & Co., Inc. | 4-aminoquinoline compounds |
| US20060142277A1 (en) * | 2002-11-15 | 2006-06-29 | Cadila Healthcare Limited | Substituted aralkyl derivatives |
| JPWO2004069798A1 (ja) * | 2003-02-10 | 2006-05-25 | 萬有製薬株式会社 | ピペリジン誘導体を有効成分とするメラニン凝集ホルモン受容体拮抗剤 |
| DE10308355A1 (de) | 2003-02-27 | 2004-12-23 | Aventis Pharma Deutschland Gmbh | Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel |
| WO2006039334A1 (en) * | 2004-09-29 | 2006-04-13 | Schering Corporation | Combinations of substituted azetidonones and cb1 antagonists |
| GB0505969D0 (en) | 2005-03-23 | 2005-04-27 | Novartis Ag | Organic compounds |
| WO2006105127A2 (en) | 2005-03-31 | 2006-10-05 | Takeda San Diego, Inc. | Hydroxysteroid dehydrogenase inhibitors |
| WO2007002557A1 (en) * | 2005-06-28 | 2007-01-04 | Merck & Co., Inc. | Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| WO2007021803A1 (en) * | 2005-08-12 | 2007-02-22 | Schering Corporation | Compounds for the treatment of inflammatory disorders |
| ZA200802857B (en) | 2005-09-14 | 2009-09-30 | Takeda Pharmaceutical | Dipeptidyl peptidase inhibitors for treating diabetes |
| KR101368988B1 (ko) | 2005-09-16 | 2014-02-28 | 다케다 야쿠힌 고교 가부시키가이샤 | 디펩티딜 펩티다제 억제제 |
| BRPI0620736A2 (pt) | 2005-12-30 | 2011-12-20 | Novartis Ag | compostos orgánicos |
| WO2007112347A1 (en) | 2006-03-28 | 2007-10-04 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| US8324383B2 (en) | 2006-09-13 | 2012-12-04 | Takeda Pharmaceutical Company Limited | Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile |
| TW200838536A (en) | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
| US8093236B2 (en) | 2007-03-13 | 2012-01-10 | Takeda Pharmaceuticals Company Limited | Weekly administration of dipeptidyl peptidase inhibitors |
| ES2541107T3 (es) | 2007-06-25 | 2015-07-16 | Novartis Ag | Derivados de N5-(2-etoxietil)-N3-(2-piridinil)-3,5-piperidindicarboxamida para su uso como inhibidores de renina |
| JP2012512221A (ja) * | 2008-12-16 | 2012-05-31 | エフ．ホフマン−ラ ロシュ アーゲー | ピロリジン−３−カルボン酸の製造方法 |
| FR2941457A1 (fr) * | 2009-01-28 | 2010-07-30 | Sanofi Aventis | Derives de thiadiazoles et d'oxadiazoles leur preparation et leur application en therapeutique |
| AR075177A1 (es) * | 2009-01-28 | 2011-03-16 | Sanofi Aventis | Derivados de tiadiazoles y oxadiazoles, metodo de preparacion, intermediarios de sintesis, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de trastornos metabolicos, tales como obesidad y diabetes, entre otros. |
| BR112012007979A2 (pt) * | 2009-10-06 | 2016-03-29 | Bristol Myers Squibb Co | moduladores de gpr40 de pirrolidina |
| NZ604035A (en) | 2010-06-04 | 2015-02-27 | Albany Molecular Res Inc | Glycine transporter-1 inhibitors, methods of making them, and uses thereof |
| PT2800738T (pt) | 2012-01-06 | 2020-06-23 | Novartis Ag | Compostos heterocíclicos e métodos para a utilização dos mesmos |
| NZ627560A (en) * | 2012-01-25 | 2016-08-26 | Novartis Ag | Heterocyclic piperazine compounds and methods for their use |
| AU2013344604B2 (en) | 2012-11-16 | 2017-07-27 | Bristol-Myers Squibb Company | Dihydropyrazole GPR40 modulators |
| WO2014130311A1 (en) * | 2013-02-19 | 2014-08-28 | Sun Chemical Corporation | Printable radiation curable barrier coatings |
| US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
| US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
| JP2017119628A (ja) * | 2014-05-09 | 2017-07-06 | 日産化学工業株式会社 | 置換アゾール化合物及び糖尿病治療薬 |
| CN107677753B (zh) * | 2017-11-24 | 2021-03-16 | 中山奕安泰医药科技有限公司 | 一种依替米贝中间体的检测方法 |
| US11034669B2 (en) | 2018-11-30 | 2021-06-15 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
| CN112876427B (zh) * | 2021-01-18 | 2022-04-22 | 万华化学集团股份有限公司 | 一种安赛蜜的制备方法 |
| CN112679407B (zh) * | 2021-03-17 | 2021-06-04 | 南京桦冠生物技术有限公司 | 一种手性5-取代脯氨酸类化合物的制备方法 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05213884A (ja) | 1991-06-14 | 1993-08-24 | Upjohn Co:The | 新規な４−アミノキノリン類およびこれを有効成分とする高血圧・鬱血性心不全の予防・治療剤 |
| GB9113628D0 (en) | 1991-06-25 | 1991-08-14 | Ici Plc | Heterocyclic derivatives |
| US5631365A (en) * | 1993-09-21 | 1997-05-20 | Schering Corporation | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
| JP3290664B2 (ja) | 1993-12-28 | 2002-06-10 | 明治製菓株式会社 | ３環性ベンゾアゼピンおよびベンゾチアゼピン誘導体 |
| JPH08325263A (ja) | 1995-05-31 | 1996-12-10 | Sumitomo Metal Ind Ltd | 新規２−アミノ−３−フェニルプロピオン酸誘導体 |
| US6143718A (en) * | 1995-06-07 | 2000-11-07 | Amylin Pharmaceuticals, Inc. | Treatment of Type II diabetes mellutis with amylin agonists |
| US6093714A (en) | 1995-06-15 | 2000-07-25 | Meiji Seika Kaisha, Ltd. | Tricyclic benzazepine compounds |
| AU719146B2 (en) | 1996-02-02 | 2000-05-04 | Merck & Co., Inc. | Antidiabetic agents |
| WO1997028149A1 (en) | 1996-02-02 | 1997-08-07 | Merck & Co., Inc. | Method for raising hdl cholesterol levels |
| AU712607B2 (en) | 1996-02-02 | 1999-11-11 | Merck & Co., Inc. | Method of treating diabetes and related disease states |
| WO1997028137A1 (en) | 1996-02-02 | 1997-08-07 | Merck & Co., Inc. | Heterocyclic derivatives as antidiabetic and antiobesity agents |
| GB9604242D0 (en) | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
| CA2259431A1 (en) | 1996-07-01 | 1998-01-08 | Eli Lilly And Company | Hypoglycemic and hypolipidemic compounds |
| EP0925063A4 (en) | 1996-07-01 | 2000-12-27 | Lilly Co Eli | Blood-glucose-lowering and lipid-lowering compounds |
| EP0948327B1 (en) | 1996-12-23 | 2006-03-08 | Merck & Co., Inc. | Antidiabetic agents |
| WO1999007357A1 (fr) | 1997-08-08 | 1999-02-18 | Ono Pharmaceutical Co., Ltd. | REGULATEURS DE TYPE η DE RECEPTEUR ACTIVE D'AGENT DE PROLIFERATION DE PEROXYSOME |
| AU8750298A (en) | 1997-08-28 | 1999-03-22 | Ono Pharmaceutical Co. Ltd. | Peroxisome proliferator-activated receptor controllers |
| WO1999015520A1 (fr) | 1997-09-19 | 1999-04-01 | Ono Pharmaceutical Co., Ltd. | Composes de benzene fusionnes ou non fusionnes |
| EP1026167B1 (en) | 1997-09-29 | 2003-03-05 | Meiji Seika Kaisha Ltd. | Tricyclic triazolobenzazepine derivatives, process for producing the same and antiallergic agents |
| CN1302206A (zh) | 1997-10-17 | 2001-07-04 | 阿温蒂斯药物制品公司 | 喹啉衍生物的治疗用途 |
| WO1999016758A1 (en) | 1997-10-27 | 1999-04-08 | Dr. Reddy's Research Foundation | Novel heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| JP4345230B2 (ja) * | 1998-03-10 | 2009-10-14 | 小野薬品工業株式会社 | カルボン酸誘導体およびその誘導体を有効成分として含有する薬剤 |
| DE69828445D1 (de) | 1998-04-23 | 2005-02-03 | Reddys Lab Ltd Dr | Heterozyklische verbindungen,und deren verwendung in arzneimittel,verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen |
| EP1091943B1 (en) * | 1998-06-30 | 2005-11-30 | Pfizer Products Inc. | Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| GB9817118D0 (en) | 1998-08-07 | 1998-10-07 | Glaxo Group Ltd | Pharmaceutical compounds |
| ATE368037T1 (de) | 1999-04-28 | 2007-08-15 | Sanofi Aventis Deutschland | Di-aryl-säurederivate als ppar rezeptor liganden |
| BR0010126A (pt) | 1999-04-28 | 2002-02-26 | Aventis Pharma Gmbh | Derivados de ácido tri-arìlico como ligandos receptores de ppar |
| US6414002B1 (en) * | 1999-09-22 | 2002-07-02 | Bristol-Myers Squibb Company | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| TW200514783A (en) * | 1999-09-22 | 2005-05-01 | Bristol Myers Squibb Co | Substituted acid derivatives useful as antiodiabetic and antiobesity agents and method |
| SK6432002A3 (en) * | 1999-11-10 | 2003-02-04 | Takeda Chemical Industries Ltd | 5-Membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| US7105556B2 (en) * | 2001-05-30 | 2006-09-12 | Bristol-Myers Squibb Company | Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method |
| US6967212B2 (en) * | 2001-05-30 | 2005-11-22 | Bristol-Myers Squibb Company | Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method |
-
2003
- 2003-07-02 PL PL03374860A patent/PL374860A1/xx not_active Application Discontinuation
- 2003-07-02 WO PCT/US2003/022149 patent/WO2004004665A2/en active Application Filing
- 2003-07-02 EP EP03763485A patent/EP1656368A4/en not_active Withdrawn
- 2003-07-02 AU AU2003259131A patent/AU2003259131A1/en not_active Abandoned
- 2003-07-02 JP JP2004520148A patent/JP4579681B2/ja not_active Expired - Fee Related
- 2003-07-07 TW TW092118514A patent/TW200422298A/zh unknown
- 2003-07-08 US US10/616,365 patent/US7279485B2/en active Active
-
2005
- 2005-01-05 IS IS7630A patent/IS7630A/is unknown
- 2005-01-06 NO NO20050077A patent/NO329938B1/no not_active IP Right Cessation
-
2007
- 2007-07-18 US US11/779,319 patent/US7951793B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005536494A5 (ja) | ||
| EP2233572A3 (en) | Genes and polypeptides relating to human colon cancers | |
| CN101362718B (zh) | 4-(4-苯甲酰氨基苯氧基)-2-(甲基氨甲酰基)吡啶衍生物及其制备方法和用途 | |
| JP2005508318A5 (ja) | ||
| Anderson et al. | Plummer-Vinson syndrome heralded by postcricoid carcinoma | |
| Kumar et al. | Design, synthesis, hypoglycemic activity and molecular docking studies of 3-substituted-5-[(Furan-2-yl)-methylene]-thiazolidine-2, 4-dione derivatives | |
| Zhang et al. | Obesity and cancer | |
| Martín et al. | 2-Alkoxydihydrocinnamates as PPAR agonists. Activity modulation by the incorporation of phenoxy substituents | |
| CN108191719A (zh) | 一种含砜类取代的查尔酮类似物、其制备方法及其医药用途 | |
| CN102276445B (zh) | 一种胶体酒石酸铋化合物及其药物及制备方法和应用 | |
| CN106957252A (zh) | 一种质子泵抑制剂中间体及其制备方法 | |
| EP2612861B1 (en) | Fluorinated thiazoles for use in treating cancer | |
| Jain et al. | Xanthelasma of the stomach-A rare pseudotumor | |
| Plavšić et al. | Radiologic and endoscopic diagnosis of duodenal angioma | |
| Singer et al. | Endoscopic polypectomy in the upper gastrointestinal tract | |
| Namikawa et al. | Unusual thickened gastric folds in a patient with breast cancer | |
| Khavkin et al. | Chronic gastritis in children: new potentials for diet therapy | |
| ARMSTRONG et al. | Recurrent carcinoid tumor of the colon | |
| Livadariu et al. | Upper Digestive Endoscopy Prior to Bariatric Surgery in Morbidly Obese Patients-A Retrospective Analysis | |
| Selvarajah et al. | Inflammatory fibroid polyp (Vanek's tumour) of the ileum causing ileocolic intussusception | |
| JP2007508270A5 (ja) | ||
| Bencheqroun et al. | Cowden syndrome, first case investigated using electronic video capsule | |
| JP2007523131A5 (ja) | ||
| Baghmar et al. | Cutaneous metastasis from intrahepatic cholangiocarcinoma | |
| Abughanimeh et al. | Posterior Reversible Encephalopathy Syndrome (PRES) in a Patient with Metastatic Gastric Cancer While Receiving FOLFIRI Chemotherapy: A Case Report: 2288 |